Application of the brace framework for benefit-risk assessment, communication, and evaluation of Pexidartinib

被引:0
|
作者
Wang, Eric [1 ]
Dharmani, Charles [1 ]
Salas, Maribel [1 ]
机构
[1] Daiichi Sankyo Inc, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
333
引用
收藏
页码:145 / 146
页数:2
相关论文
共 50 条
  • [1] The Patient's Voice in the Heart of BRACE (Benefit-Risk Assessment, Communication and Evaluation)
    Smith, Meredith
    Bahri, Priya
    Dal Pan, Gerald
    Banerjee, Swapu
    Mol, Peter
    Dey, Debashish
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 364 - 365
  • [2] Benefit-Risk Assessment, Communication and Evaluation (BRACE): Embrace the Challenges and Opportunities (Submitted on Behalf of the BRACE SIG)
    Noel, Rebecca
    Primatesta, Paola
    Dal Pan, Gerald
    Wolf, Michael
    Smith, Meredith
    Bahri, Priya
    Morrato, Elaine
    Dey, Debashish
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 39 - 39
  • [3] Implementing Benefit-Risk Assessment for the Periodic Benefit-Risk Evaluation Report
    Warner, Margaret R.
    Wolka, Anne M.
    Noel, Rebecca A.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (03) : 342 - 346
  • [4] Implementing Benefit-Risk Assessment for the Periodic Benefit-Risk Evaluation Report
    Margaret R. Warner
    Anne M. Wolka
    Rebecca A. Noel
    Therapeutic Innovation & Regulatory Science, 2016, 50 : 342 - 346
  • [5] Benefit-Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist
    Radawski, Christine
    Morrato, Elaine
    Hornbuckle, Kenneth
    Bahri, Priya
    Smith, Meredith
    Juhaeri, Juhaeri
    Mol, Peter
    Levitan, Bennett
    Huang, Han-Yao
    Coplan, Paul
    Li, Hu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 (12) : 1233 - 1240
  • [6] A Unified Framework for Classification of Methods for Benefit-Risk Assessment
    Najafzadeh, Mehdi
    Schneeweiss, Sebastian
    Choudhry, Niteesh
    Bykov, Katsiaryna
    Kohler, Kristijan H.
    Martin, Diane P.
    Gagne, Joshua J.
    VALUE IN HEALTH, 2015, 18 (02) : 250 - 259
  • [7] A UNIFIED FRAMEWORK FOR CLASSIFICATION OF METHODS FOR BENEFIT-RISK ASSESSMENT
    Najafzadeh, M.
    Schneeweiss, S.
    Choudhry, N. K.
    Bykov, K.
    Kahler, K.
    Martin, D.
    Arcona, S.
    Rogers, J. R.
    Gagne, J. J.
    VALUE IN HEALTH, 2014, 17 (03) : A3 - A3
  • [8] A Unified Framework for Classification of Methods for Benefit-Risk Assessment
    Najafzadeh, Mehdi
    Schneeweiss, Sebastian
    Choudhry, Niteesh K.
    Bykov, Kate
    Kahler, Kristijan
    Martin, Diane P.
    Arcona, Stephen
    Gagne, Joshua J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 240 - 241
  • [9] Evaluation of Benefit-Risk
    Garattini, Silvio
    PHARMACOECONOMICS, 2010, 28 (11) : 981 - 986
  • [10] Evaluation of Benefit-Risk
    Silvio Garattini
    PharmacoEconomics, 2010, 28 : 981 - 986